← Back to Search

Patients who received intravenous PCA following surgery at the UHN for Pain relief

N/A
Waitlist Available
Led By Laura Giron-Arango, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 48 hours after surgery
Awards & highlights

Summary

The numeric rating scale (NRS) is one way to assess how much pain a patient is feeling after surgery, ranging from 0 (no pain) to 10 (the worst pain imaginable). The score getting lower can thus indicate pain relief. However, a small change in the score does not mean that the patient is actually satisfied with their pain relief treatment. The PASS (patient acceptable symptom state) is the score threshold beyond which a patient considers their treatment satisfactory. The purpose of this observational study is to find out the PASS for the NRS in the first 48 hours after surgery. This will help guide future research on pain medicine, so that new techniques can deliver adequate patient satisfaction.

Eligible Conditions
  • Pain relief

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 48 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 48 hours after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PASS for the NRS
Secondary study objectives
Consistency of PASS for the NRS
MCID for the NRS
Opioid dose needed to achieve PASS for the NRS
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients who received intravenous PCA following surgery at the UHNExperimental Treatment1 Intervention
Patients who received intravenous PCA following surgery at the UHN from the period of June 4, 2022 to December 31, 2023.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,514 Previous Clinical Trials
493,205 Total Patients Enrolled
Laura Giron-Arango, MDPrincipal InvestigatorUHN
1 Previous Clinical Trials
40 Total Patients Enrolled
~2333 spots leftby Oct 2024